Capita plc:企業の戦略・SWOT・財務分析

◆英語タイトル:Capita plc - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4722
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Technology and Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Capita plc – Strategy, SWOT and Corporate Finance Report
Summary

Capita plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Capita plc (Capita or ‘the company’) is a provider of business process management (BPM) and integrated professional support service solutions. The company provides people solutions, specialist services, networks solutions, IT services and application software and solutions. Its major IT services and solutions include data centre and cloud infrastructure, testing, managed IT support, managed networks, cybersecurity and consulting. The company offers its solutions and services to various sectors, including financial services, defense, education, automotive, emergency services, government, healthcare, housing, retail, telecoms and media, transport, travel and leisure, and utilities. Capita primarily operates in the UK, India, Switzerland, the US, Australasia, Europe, Poland, South Africa, Germany and the UAE. The company is headquartered in London, the UK.

Scope

- Detailed information on Capita plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Capita plc in the form of a SWOT analysis
- An in-depth view of the business model of Capita plc including a breakdown and examination of key business segments
- Intelligence on Capita plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Capita plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Capita plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Capita plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Capita plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Capita plc: Company Overview
Capita plc: Overview and Key Facts
Capita plc: Overview
Capita plc: Key Facts
Capita plc: Key Employees
Capita plc: Key Employee Biographies
Capita plc: Major Products and Services
Capita plc: Company History
Capita plc: Locations and Subsidiaries
Capita plc: Key Competitors
Capita plc: Company Analysis
Capita plc: Business Description
Capita plc: SWOT Analysis
Capita plc: SWOT Overview
Capita plc: Strengths
Capita plc: Weaknesses
Capita plc: Opportunities
Capita plc: Threats
Capita plc: Corporate Financial Deals Activity
Capita plc: Financial Deals Overview
Capita plc: Targets and Partners
Capita plc: Top Deals 2016 – 2020YTD*
Capita plc: Advisors
Capita plc: Top Legal Advisors
Capita plc: Top Financial Advisors
Capita plc: Mergers and Acquisitions
Capita plc: Capital Raising
Capita plc: Divestments
Capita plc: Recent Developments
Capita plc: News and Events Summary
Capita plc: Business Expansion
Capita plc: Contracts
Capita plc: Corporate Governance
Capita plc: Financial Deals
Capita plc: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Capita plc: Key Facts
Table 2: Capita plc: Key Employees
Table 3: Capita plc: Company History
Table 4: Capita plc: Locations and Subsidiaries
Table 5: Capita plc: Key Competitors
Table 6: Capita plc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Capita plc: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Capita plc: M&A Average Deal Size - Value (US$m)
Table 9: Capita plc: Targets and Partners
Table 10: Capita plc: Top Deals 2016 - 2020YTD*
Table 11: Capita plc: Legal Advisor Ranking by Value (US$m)
Table 12: Capita plc: Financial Advisor Ranking by Value (US$m)
Table 13: Capita plc: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: Capita plc: M&A Activity by Geography (2016 - YTD*2020)
Table 15: Capita plc: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 16: Capita plc: Capital Raising by Deal Type (2016 - YTD*2020)
Table 17: Capita plc: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 18: Capita plc: Divestments by Geography (2016 - YTD*2020)
Table 19: Capita plc: News and Events Summary
Table 20: Capita plc: Business Expansion
Table 21: Capita plc: Contracts
Table 22: Capita plc: Corporate Governance
Table 23: Capita plc: Financial Deals
Table 24: Capita plc: Strategy and Operations

★海外企業調査レポート[Capita plc:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gecko Biomedical:企業の製品パイプライン分析2018
    Summary Gecko Biomedical (Gecko) is a life science company that provides polymer solutions for tissue reconstruction. The company offers a platform that validates the technology in surgical spaces, including peripheral nerve reconstruction, ophthalmology, urology, and orthopaedics. It also provides …
  • Enterprise Ireland:医療機器:M&Aディール及び事業提携情報
    Summary Enterprise Ireland (EI) is an economic development organization that offers enterprise development programs. The organization’s activities include funding supports, export assistance, supports to develop competitiveness, incentives to stimulate in-company research and development, assistance …
  • Institute of Cancer Research-製薬・医療分野:企業M&A・提携分析
    Summary Institute of Cancer Research (ICR), a subsidiary of University of London is a research institute that offers cancer research and education programs. The institute conducts research and develops new therapies for the treatment of cancer including breast and lung cancer. It offers various post …
  • Metacrine Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Metacrine Inc (Metacrine) is a clinical-stage biopharmaceutical company that focuses on the development of therapies for the treatment of patients with liver and gastrointestinal diseases. The company develops its proprietary portfolio of non-bile acid FXR agonists through its chemistry and …
  • Sekisui House Ltd (1928):企業の財務・戦略的SWOT分析
    Sekisui House Ltd (1928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Active Motif Inc-製薬・医療分野:企業M&A・提携分析
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products comprise antibodies, extracts, fluorescent dyes, kits, reporter assays, molecules and recombinant proteins. It offers products for transcriptional regulation, …
  • Iberdrola Ingenieria y Construccion SAU:企業の戦略・SWOT・財務情報
    Iberdrola Ingenieria y Construccion SAU - Strategy, SWOT and Corporate Finance Report Summary Iberdrola Ingenieria y Construccion SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Amedica Corp (AMDA):製品パイプライン分析
    Summary Amedica Corp (Amedica) is a biomaterial company. It develops, manufactures and markets medical-grade silicon nitride ceramics for spinal and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems and others. Amedica also offers n …
  • Boehringer Ingelheim GmbH-医療機器分野:企業M&A・提携分析
    Summary Boehringer Ingelheim GmbH (Boehringer), a subsidiary of C. H. Boehringer Sohn AG & Co KG is a pharmaceutical company, which carries out research, development, manufacture and sale of pharmaceuticals. The company offers a wide range of products including prescription medicines, consumer healt …
  • Bioverativ Inc (BIVV):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technolog …
  • Intellipharmaceutics International Inc (IPCI):製薬・医療:M&Aディール及び事業提携情報
    Summary Intellipharmaceutics International Inc (Intellipharmaceutics) is a pharmaceutical company that researches, develops, manufactures, and commercializes novel and generic targeted oral solid dosage pharmaceuticals. The company develops its controlled-release and targeted-release oral solid dosa …
  • Meredith Corporation:企業の戦略・SWOT・財務情報
    Meredith Corporation - Strategy, SWOT and Corporate Finance Report Summary Meredith Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Aviva plc:企業のM&A・事業提携・投資動向
    Aviva plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aviva plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Seoul National University Hospital:企業の戦略的SWOT分析
    Seoul National University Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Centrose LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Centrose LLC (Centrose) is a precision drug company that develops medicines to target diseased tissues. The company's product pipeline includes EDC1 (Dysadherin), EDC2 (CD147), EDC3 (CD98), EDC5 (CD44), and EDC8 (CD38). Its product EDC1 combines two proteins found in close proximity to treat …
  • Mendor Oy-医療機器分野:企業M&A・提携分析
    Summary Mendor Oy (Mendor) is a medical equipment company that designs, develops and markets advanced diabetes management products. The company’s products include portable blood glucose meter and web-based software application for the daily management of diabetes. It offers blood glucose meter mendo …
  • Ultra Petroleum Corp.:企業の戦略・SWOT・財務情報
    Ultra Petroleum Corp. - Strategy, SWOT and Corporate Finance Report Summary Ultra Petroleum Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Xinjiang Xinxin Mining Industry Co., Ltd:企業の戦略・SWOT・財務情報
    Xinjiang Xinxin Mining Industry Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Xinjiang Xinxin Mining Industry Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Grupo Nutresa SA (NUTRESA):企業の財務・戦略的SWOT分析
    Grupo Nutresa SA (NUTRESA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Sidney Kimmel Comprehensive Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Sidney Kimmel Comprehensive Cancer Center (Sidney Kimmel) is a healthcare service provider that concentrates on diagnosis, treatment, and prevention of cancer. The center’s specialties include cancer diagnostic and treatment planning, blood and bone marrow cancers, cancer immunotherapy, brai …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆